Horizon Therapeutics Public Ltd Co Long-Lived Assets
Horizon Therapeutics Public Ltd Co had Long-Lived Assets of $440.00 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2023-03-01
- 2022-12-31: Long-Lived Assets $440.00M.
- 2021-12-31: Long-Lived Assets $368.01M.
- 2020-12-31: Long-Lived Assets $223.44M.
- 2019-12-31: Long-Lived Assets $69.96M; Long-Lived Assets as first filed $30.16M.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2022-12-31 | $440.00M 10-K · filed 2023-03-01 | |
| 2021-12-31 | $368.01M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $223.44M 10-K · filed 2023-03-01 | |
| 2019-12-31 | $69.96M 10-K · filed 2021-02-24 | $30.16M 10-K · filed 2020-02-26 |
| 2018-12-31 | $20.10M 10-K · filed 2020-02-26 | |
| 2017-12-31 | $20.41M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $23.48M 10-K · filed 2018-02-28 | |
| 2015-12-31 | $14.02M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $7.24M 10-K · filed 2016-02-29 |